2010 Annual Meeting | Poster Session 02

Date Tuesday 04/13/10

Time 03:00 PM - 07:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, History of Neurology, Sleep, Aging and Dementia, Anterior Horn, Critical Care/Emergency Neurology/Trauma, Epilepsy, Ethics, Pain and Palliative Care, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neural Repair/Rehabilitation

CME Available No CME available

Event Timeline
03:00 PM - 04:30 PM		Break
03:00 PM - 07:30 PM	Abstract	001 - The Contributions of Two Presidents of Israel to the Development of Copaxone
03:00 PM - 07:30 PM	Abstract	002 - Seasonal Patterns of Nutritional Night Blindness in the U.S. Army during the Civil War
03:00 PM - 07:30 PM	Abstract	003 - A Continuum of Ideas of Hughlings-Jackson and Wilder Penfield about Epilepsy and Brain Function
03:00 PM - 07:30 PM	Abstract	004 - Nutritional Night Blindness and Keratomalacia among Malnourished Civilians during WWI
03:00 PM - 07:30 PM	Abstract	005 - Migraine in Dr. Faustus by Thomas Mann
03:00 PM - 07:30 PM	Abstract	006 - A Biology of the Mind: Phrenology in Medicine in Antebellum America
03:00 PM - 07:30 PM	Abstract	007 - Surreptitious Documentation of Thiamin-Deficiency Disorders by Allied POWs during WWII
03:00 PM - 07:30 PM	Abstract	008 - Elementary My Dear Dr. Allen: The Case of Barium Toxicity and Pa Ping
03:00 PM - 07:30 PM	Abstract	009 - Pathogenesis and Treatment of Infantile Beriberi in the Philippines, 1910-1912
03:00 PM - 07:30 PM	Abstract	010 - The Dorsal Columns, beyond Proprioception and Vibration Sense a Historical Review
03:00 PM - 07:30 PM	Abstract	011 - Pellagra Was the First Neurodegenerative and Redox Disorder To Be Cured: Can We Be Sure It Was Eliminated?
03:00 PM - 07:30 PM	Abstract	012 - Neurology and the Old Testament
03:00 PM - 07:30 PM	Abstract	013 - Descriptions of Parkinson's Disease in Ancient Indian Medical Literature
03:00 PM - 07:30 PM	Abstract	014 - Abraham Levinson (A.L.) - His Contributions to Child Neurology
03:00 PM - 07:30 PM	Abstract	015 - Decreased Creativity after Stroke - Christoph Willibald Gluck
03:00 PM - 07:30 PM	Abstract	016 - Dystrophica Myotonica and the Legacy of Hans Steinert
03:00 PM - 07:30 PM	Abstract	017 - Neuro-Expressionism in Christfried Jakob Contributions from Lake Jakob to Visceral Brain
03:00 PM - 07:30 PM	Abstract	018 - Medical and Neurological Maladies of Sir George Everest
03:00 PM - 07:30 PM	Abstract	019 - Charcot's Son, Commander Jean-Baptiste Charcot: From Neurology to "Pourquoi Pas?"
03:00 PM - 07:30 PM	Abstract	020 - A Brief History of Endovascular Neurology and Procedures
03:00 PM - 07:30 PM	Abstract	021 - Early Contributions to the Understanding of Frontotemporal Lobar Degeneration from Argentina
03:00 PM - 07:30 PM	Abstract	023 - Trends in Outcomes and Hospitalization Costs among Spinal Cord Injury Adult Patients in the United States
03:00 PM - 07:30 PM	Abstract	024 - Post-Traumatic Cerebral Atrophy: Relationship with Diffusion Tensor Imaging Measures of Traumatic Axonal Injury
03:00 PM - 07:30 PM	Abstract	025 - Trends in Outcomes and Hospitalization Costs among Traumatic Brain Injury in Pediatric Patients in the United States
03:00 PM - 07:30 PM	Abstract	026 - Use of Diffusion Weighted Imaging To Assess Cytotoxic and Interstitial Edema after Traumatic Brain Injury
03:00 PM - 07:30 PM	Abstract	027 - Regional Selectivity of Post-Traumatic Cerebral Atrophy
03:00 PM - 07:30 PM	Abstract	028 - Trends in Outcomes and Hospitalization Costs among Traumatic Brain Injury in Adult Patients in the United States
03:00 PM - 07:30 PM	Abstract	029 - Can a Clinical Measure of Reaction Time Predict a Functional Sport-Protective Response? Implications for Sport Concussion Management
03:00 PM - 07:30 PM	Abstract	030 - Wild Bootstrap Analysis Detects Subject-Specific Changes in DTI Indices after Concussion
03:00 PM - 07:30 PM	Abstract	031 - Outcome after Mild Traumatic Brain Injury: The Role of Gender
03:00 PM - 07:30 PM	Abstract	032 - Traumatic Brain Injury - Kids in Transition
03:00 PM - 07:30 PM	Abstract	033 - Dual Intraventricular Catheter Use in Severe Intraventricular Hemorrhage
03:00 PM - 07:30 PM	Abstract	034 - Predictors and Impact of Hematoma Resorption in Medically Treated Patients with Intracerebral Hemorrhage
03:00 PM - 07:30 PM	Abstract	035 - Impact of Early Goal-Directed Hemodynamic Optimization on Clinical Management and Outcome after Subarachnoid Hemorrhage: A Prospective Controlled Study
03:00 PM - 07:30 PM	Abstract	036 - Extravascular Lung Water and Pulmonary Permeability Dynamics in Patients with Neurogenic Pulmonary Edema after Subarachnoid Hemorrhage
03:00 PM - 07:30 PM	Abstract	037 - Cell Proliferation in Chronic Subdural Hematomas: A Potential Mechanism of Expansion and Recurrence
03:00 PM - 07:30 PM	Abstract	038 - Peripheral Leukocyte Count and Matrix Metalloproteinase-2 in Cerebral Vasospasm Following Subarachnoid Hemorrhage
03:00 PM - 07:30 PM	Abstract	039 - Vasospasm in Aneurysmal SAH and Intracranial Calcification
03:00 PM - 07:30 PM	Abstract	040 - Predictors and Outcome of Pneumonia in Patients with Spontaneous Intracerebral Hemorrhage
03:00 PM - 07:30 PM	Abstract	041 - Correlation of External Cardiac Output Monitoring to Hemodynamic Parameters and Central Venous Pressure Readings in Critically Ill Neurological Patients
03:00 PM - 07:30 PM	Abstract	042 - Semantic Dementia Associated with Motor Neuron Disease: Clinicopathological Correlation
03:00 PM - 07:30 PM	Abstract	043 - Fronto-Temporal Dementia Associated with Primary Lateral Sclerosis in the Antemortem
03:00 PM - 07:30 PM	Abstract	044 - Divergent Network Connectivity Changes in Behavioral Variant FTD and Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	045 - An Anatomopathological Classification of Frontotemporal Lobar Degeneration
03:00 PM - 07:30 PM	Abstract	046 - Correlates of Alzheimer's Pathology in Corticobasal Syndrome
03:00 PM - 07:30 PM	Abstract	047 - Pre- and Post-Memantine FDG-PET Imaging in Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	048 - Prediction of Underlying Alzheimer's Disease in Corticobasal Syndrome
03:00 PM - 07:30 PM	Abstract	049 - Functional Profile of Patients with Early Frontotemporal Dementia and Its Relation with Executive Functions
03:00 PM - 07:30 PM	Abstract	050 - Anosognosia and Behavioral Manifestations of Dementia
03:00 PM - 07:30 PM	Abstract	051 - Personality in Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	052 - Neuropsychological Performance in MCI at Baseline: Effect of Apolipoprotein E [epsilon]4 Allele and Other Candidate Genetic Variants
03:00 PM - 07:30 PM	Abstract	053 - Self Administered Gerocognitive Examination (SAGE) and Mini-Mental State Examination (MMSE) Score Changes over Time in Worried Well, Mild Cognitive Impairment (MCI) and Dementia Converter Patients
03:00 PM - 07:30 PM	Abstract	054 - Impact of Mild Cognitive Impairment (MCI) on Patients and Their Caregivers
03:00 PM - 07:30 PM	Abstract	055 - Learning, Retrieval and Recognition Are Compromised in aMCI and Mild AD: Are Distinct Memory Processses Mediated by the Same Anatomical Structures?
03:00 PM - 07:30 PM	Abstract	056 - PreMCI and MCI: Comparative Neuropsychological, Clinical and Imaging Features and Progression Rates
03:00 PM - 07:30 PM	Abstract	057 - Hippocampal Atrophy Mediates the Associations between APOE-[epsilon]4 and Amnestic MCI and Verbal Memory
03:00 PM - 07:30 PM	Abstract	058 - Prevalence of Mild Cognitive Impairment by Multiple Classifications: A Population-Based Study
03:00 PM - 07:30 PM	Abstract	059 - Amnestic and Non-Amnestic Mild Cognitive Impairment and Cardiovascular Risk Factors in The 90+ Study
03:00 PM - 07:30 PM	Abstract	060 - Dementia = (MC)2: A Four Item Screening Test for Mild Cognitive Impairment and Dementia
03:00 PM - 07:30 PM	Abstract	061 - Home-Based Activity Changes Associated with MCI
03:00 PM - 07:30 PM	Abstract	062 - Dyslipidemia in Alzheimer's Disease Is Associated with Blood-Brain Barrier Impairment
03:00 PM - 07:30 PM	Abstract	063 - Comparison of the Montreal Cognitive Assessment (MoCA) with the Mini-Mental State Examination in Cognitively Impaired and Cognitively Normal Subjects as Assessed by Neuropsychological Testing
03:00 PM - 07:30 PM	Abstract	064 - Anxiety as a Possible Diagnosis Criteria for Logopenic Primary Progressive Aphasia and Pure Progressive Amnesia
03:00 PM - 07:30 PM	Abstract	065 - Frequency of Sensory Symptoms and Abnormal Nerve Conduction Studies in a SCJD Cohort
03:00 PM - 07:30 PM	Abstract	066 - Evaluation of Episodic Memory in Illiterate and Low-Educated Patients
03:00 PM - 07:30 PM	Abstract	067 - Alzheimer's Disease CSF Biomarker Levels Correlate with Baseline Cognitive Performance and Post-Shunt Cognitive Outcomes in Normal Pressure Hydrocephalus
03:00 PM - 07:30 PM	Abstract	068 - Obsessive Compulsive Symptom Profile in Patients with Behavioral Variant Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	069 - The Boston Driving Screen - Validation of a Clinical Tool for Assessing Driving Problems in the Elderly
03:00 PM - 07:30 PM	Abstract	070 - Free Will, Decision-Making and the Frontal Lobes: Unique Legal and Ethical Aspects in the Early Stages of the Behavioral Variant Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	071 - Clinical Phenotype of Dementia after Traumatic Brain Injury (TBI)
03:00 PM - 07:30 PM	Abstract	072 - Cervical Artery Dissection: A 5-Year Experience of a Tertiary Care Center
03:00 PM - 07:30 PM	Abstract	073 - Brain Stem and Cerebellar Strokes Are Less Cardioembolic and Less Severe Than Hemispheric Strokes. Prospective Data from the National Acute Stroke Israeli Surveys (NASIS)
03:00 PM - 07:30 PM	Abstract	074 - Does National Institutes of Health Stroke Scale Score Provide Additional Predictive Value in Good Grade Patients with Intracerebral Hemorrhage? Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Study
03:00 PM - 07:30 PM	Abstract	075 - Epidemiology and Outcomes of Fever Burden among Patients with Acute Ischemic Stroke
03:00 PM - 07:30 PM	Abstract	076 - Admitted Transient Ischemic Attack Patients Have a Lower 2-Day Risk of Ischemic Stroke Than Predicted by the ABCD2 Score
03:00 PM - 07:30 PM	Abstract	077 - Incidence of Falling among Elderly with History of Stroke: Health and Retirement Study Survey 2002-2006
03:00 PM - 07:30 PM	Abstract	078 - Antecedent Chiropractic Manipulation May Be More Frequently Associated with Posterior Circulation Territory Strokes
03:00 PM - 07:30 PM	Abstract	079 - The NIH Score: Predicting the Need for In-Patient Hospitalization (NIH) of TIA Patients
03:00 PM - 07:30 PM	Abstract	080 - Factors Influencing Early Cognitive Impairment after Stroke
03:00 PM - 07:30 PM	Abstract	081 - Alcohol Consumption and Other Vascular Risk Factors Associated with White Matter Subcortical Lesions in Non-Demented Non-Stroke
03:00 PM - 07:30 PM	Abstract	082 - Clinical and Radiological Predictors of Neurological Deterioration in Spontaneous Cervico-Carotid Dissections
03:00 PM - 07:30 PM	Abstract	083 - Transcranial Doppler (TCD) and Neurological Manifestations in Brazilian Pediatric Patients with SCD
03:00 PM - 07:30 PM	Abstract	084 - The Interval of Stenotic Index of TCD and Middle Cerebral Artery Stenosis
03:00 PM - 07:30 PM	Abstract	085 - Frequency of Emergency Physician and Neurologist Agreement in the Diagnosis of TIA
03:00 PM - 07:30 PM	Abstract	086 - Clinical and Radiological Features of Reversible Cerebral Vasoconstriction Syndrome
03:00 PM - 07:30 PM	Abstract	087 - Characterization of Ischemic Strokes and Transient Ischemic Attacks after Cardiovascular Procedures in a High-Volume Center
03:00 PM - 07:30 PM	Abstract	088 - Preparation for Accreditation and State Designation of a Comprehensive Stroke Center Improves Stroke Case Volume, Evaluation and Treatment Response Times
03:00 PM - 07:30 PM	Abstract	089 - Characterization of Large Hemispheric Infarction
03:00 PM - 07:30 PM	Abstract	090 - Vitamin D Deficiency and Stroke Severity
03:00 PM - 07:30 PM	Abstract	091 - Safety, Feasibility, and Advantages of Tapering Antihypertensive Agents in Older Adults Preparing for Enrollment in a Cognitive Clinical Trial
03:00 PM - 07:30 PM	Abstract	092 - Effect of Early Decompressive Hemicraniectomy in Patients with Malignant Middle Cerebral Artery Infarction
03:00 PM - 07:30 PM	Abstract	093 - Current Diagnosis and Management of Cerebral Venous Thrombosis in Buenos Aires, Argentina
03:00 PM - 07:30 PM	Abstract	094 - A Study of Reflex and Voluntary Cough after Acute Ischaemic Stroke
03:00 PM - 07:30 PM	Abstract	095 - The Role of Indoleamine 2,3-Dioxygenase Acitivation in the Eitiology of Post-Stroke Depression
03:00 PM - 07:30 PM	Abstract	096 - Leukocyte-Platelet Complex Formation as a Predictor of Clinical Outcome in the Acute and Convalescent Phases of Ischemic Stroke
03:00 PM - 07:30 PM	Abstract	097 - Basilar Artery Occlusion in Young Adults
03:00 PM - 07:30 PM	Abstract	099 - Sneddon's Syndrome without Antiphospholipid Antibodies: A Report of 26 Cases with Cerebral Angiography
03:00 PM - 07:30 PM	Abstract	100 - Outcomes and Predictive Prognostic Factors in Patients with Cerebral Venous and Dural Sinus Thrombosis: Experience from a Tertiary Care Hospital in India
03:00 PM - 07:30 PM	Abstract	101 - Antihypertensive Medication Management in Acute Ischemic Stroke: Evidence from Observational Data
03:00 PM - 07:30 PM	Abstract	102 - Ipsilateral Ptosis and Astasia with Thalamic Infarct: A Case Report
03:00 PM - 07:30 PM	Abstract	103 - Prevalence and Clinicoradiological Hallmarks of Vertebrobasilar Dolichoectasia in Acute Stroke Patients
03:00 PM - 07:30 PM	Abstract	104 - Predictors of Stroke Mortality in a Nigerian Teaching Hospital
03:00 PM - 07:30 PM	Abstract	105 - Factors Which Influence the Speed of Diagnosis of Cerebral Venous Sinus Thrombosis
03:00 PM - 07:30 PM	Abstract	106 - Correlation between Two Methods of Measuring Transcranial Doppler Cerebral Vasomotor Reactivity
03:00 PM - 07:30 PM	Abstract	107 - The Effects of Uric Acid on Severity and Early Prognosis in Ischemic Stroke
03:00 PM - 07:30 PM	Abstract	108 - Thalamic Infarction Causing Astasia-Abasia, Ataxia and Asterixis: Clinical and Radiological Features of Two Cases
03:00 PM - 07:30 PM	Abstract	110 - Importance of Hormonal Medication in Young Women with Ischemic Stroke
03:00 PM - 07:30 PM	Abstract	111 - Predictors for Tracheostomy in ICH
03:00 PM - 07:30 PM	Abstract	112 - Misdiagnosis of Cerebellar Hemorrhage: Frequency of Pseudo-Gastroenteritis Clinical Presentations to the Emergency Department
03:00 PM - 07:30 PM	Abstract	113 - Factor VII for Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis
03:00 PM - 07:30 PM	Abstract	114 - An Unusual Acute Development of Superficial Siderosis
03:00 PM - 07:30 PM	Abstract	115 - Enlargement of a Distal Part of the Optic Nerve Sheath in Hyperacute Stage of Intracerebral Hemorrhage
03:00 PM - 07:30 PM	Abstract	116 - Risk Factors and Intra Cerebral Hemorrhage in African American Population
03:00 PM - 07:30 PM	Abstract	117 - Does Variance in Blood Pressure Parameters within 24 Hours, Predict Early Mortality in Patients with Intracerebral Hemorrhage?
03:00 PM - 07:30 PM	Abstract	118 - The MCA Arrow Sign in Subarachnoid Hemorrhage
03:00 PM - 07:30 PM	Abstract	119 - Does Transfer Time to a Tertiary Care Center Play a Role in Predicting Mortality in Intracranial Hemorrhage?
03:00 PM - 07:30 PM	Abstract	120 - Early Blood Pressure Hemodynamics and Their Association with Intra-Ventricular Extension of Intracerebral Hemorrhage
03:00 PM - 07:30 PM	Abstract	121 - Spontaneous ICH in Chronic Daily Alcohol Users
03:00 PM - 07:30 PM	Abstract	122 - Systemic Blood Pressure and Occurrence of Intracerebral Hemorrhage in Patients with Cerebral Venous Thrombosis
03:00 PM - 07:30 PM	Abstract	123 - Diabetic Mean Fasting Plasma Glucose Levels and Stroke Rehabilitation Outcome
03:00 PM - 07:30 PM	Abstract	124 - Quantifying Neural Cell Birth in the Pediatric Spinal Cord
03:00 PM - 07:30 PM	Abstract	125 - A New Marker for Neuroinflammation in Acute Adult Traumatic Brain Injury
03:00 PM - 07:30 PM	Abstract	126 - Importance of Raising Awareness about Head Injuries in Recreational Sports
03:00 PM - 07:30 PM	Abstract	127 - Cognitive Training and Long Term Follow-Up in Patients with Mild Cognitive Impairment
03:00 PM - 07:30 PM	Abstract	128 - Sensorimotor Cortical Changes after Botulinum Toxin Therapy for Cervical Dystonia: A Functional MRI Study
03:00 PM - 07:30 PM	Abstract	129 - Effectiveness of Virtual Reality Using Wii Gaming Technology in STroke Rehabilitation (EVREST): Results from a Randomized Clinical Trial
03:00 PM - 07:30 PM	Abstract	130 - Fibrocartilaginous Embolism: Clinical Features and Outcomes
03:00 PM - 07:30 PM	Abstract	131 - The Adverse Effect of Post-Stroke Spasticity on 3-Month Functional Outcomes
03:00 PM - 07:30 PM	Abstract	132 - Combat Veterans with Mild TBI Due to Explosions Have Persisting Neurological Deficits
03:00 PM - 07:30 PM	Abstract	133 - Frequency of Visual Field Defects in Neuro-Rehabilitation
03:00 PM - 07:30 PM	Abstract	134 - Efficacy of NT 201 (Botulinum Neurotoxin Type A, Free from Complexing Proteins) in the Treatment of Patients with Upper Limb Spasticity
03:00 PM - 07:30 PM	Abstract	135 - Diagnosing Adult Polyglucosan Body Disease: A Case Report and Review of the Literature
03:00 PM - 07:30 PM	Abstract	136 - Efficacy and Safety of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Treatments for up to 89 Weeks in Upper Limb Post-Stroke Spasticity
03:00 PM - 07:30 PM	Abstract	137 - Falls in People with Multiple Sclerosis: Frequent and Correlated with Balance Confidence and Disease Severity
03:00 PM - 07:30 PM	Abstract	138 - Scopolamine and Ketamine Modelling of Neurocognitive Deficits: Clinical Trials Applications
03:00 PM - 07:30 PM	Abstract	139 - Angiotensin II Type 1 Receptor Antibodies in Multiple Sclerosis: A New Biomarker for Disease Activity?
03:00 PM - 07:30 PM	Abstract	140 - Immunological Factors That Condition an Aggressive Multiple Sclerosis Course
03:00 PM - 07:30 PM	Abstract	141 - Predictors of Response to First-Line Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	142 - Functional Bioenergetic Measure of CD4+-Cellular Immunocompetence in Monoclonal Antibody-Associated Progressive Multifocal Leukoencephalopathy
03:00 PM - 07:30 PM	Abstract	143 - Lower Serum Creatinine Levels Correlate with Blood-Brain Barrier Dysfunction in Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	144 - The North-South MS Prevalence Gradient in Ireland in Relation to Vitamin D Status
03:00 PM - 07:30 PM	Abstract	145 - T-Cell Responses to Aquaporin-4 in Neuromyelitis Optica (NMO)
03:00 PM - 07:30 PM	Abstract	146 - Frequency and Prognostic Value of NMO-IgG Seropositivity in Isolated Optic Neuritis
03:00 PM - 07:30 PM	Abstract	147 - Rituximab in Secondary Progressive Multiple Sclerosis - One Year Follow Up
03:00 PM - 07:30 PM	Abstract	148 - Clinical Markers of Therapeutic Response [amp] the Long-Term Impact of Glatiramer Acetate on Relapse-Induced Disability
03:00 PM - 07:30 PM	Abstract	149 - Potential Factors Influencing Vitamin D Metabolism in Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	150 - Autoimmune Brainstem and Cerebellar Encephalitis with New Auto-Antibody
03:00 PM - 07:30 PM	Abstract	151 - Serum Levels of the Phosphorylated Neurofilament Heavy Chain Biomarker of Axonal Injury Is Reduced 5 Years after Treatment by Intravenous Methylprednisolone in the Optic Neuritis Treatment Trial
03:00 PM - 07:30 PM	Abstract	152 - CSF Oligoclonal Bands in Multiple Sclerosis Patients: Worse Prognosis?
03:00 PM - 07:30 PM	Abstract	153 - Prior Suggestive Symptoms in Third of Patients Consulting for a "First" Demyelinating Event
03:00 PM - 07:30 PM	Abstract	154 - Severe Multiple Sclerosis Exacerbation during the 3rd Trimester of Pregnancy Presenting with Tumefactive MRI Lesions
03:00 PM - 07:30 PM	Abstract	155 - The Cellular Immune Response Against Epstein-Barr Virus in Multiple Sclerosis and Cross-Reactivity with Brain Antigens
03:00 PM - 07:30 PM	Abstract	156 - IL-23/IL-1b Ratio as a Biomarker of Disease Activity in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	157 - Overlapping Molecular Mechanisms of Protection during Pregnancy and Disease-Modifying Therapies in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	158 - Attitudes about Physician-Assisted Suicide in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	159 - Developing an Instrument To Assess Caregiver Quality of Life in Multiple Sclerosis (CAREQOL-MS)
03:00 PM - 07:30 PM	Abstract	160 - Quality of Life in Multiple Sclerosis: Exploring Transcultural Differences
03:00 PM - 07:30 PM	Abstract	161 - Longitudinal Changes in Depression, Fatigue, Quality of Life, and Social Functioning in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Subcutaneous Interferon Beta-1a in the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) Study
03:00 PM - 07:30 PM	Abstract	162 - Establishing a Quality of Life Scale Related to Relapses in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	163 - Effects of Meditation on Pain and Quality of Life in Multiple Sclerosis and Polyneuropathy: A Controlled Study
03:00 PM - 07:30 PM	Abstract	164 - Effect of Natalizumab on Disease-Specific Quality of Life after One Year of Natalizumab Treatment
03:00 PM - 07:30 PM	Abstract	165 - Quality of Life in Benign Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	166 - Improvement in Health-Related Quality of Life in Multiple Sclerosis Patients Receiving Natalizumab in the United States
03:00 PM - 07:30 PM	Abstract	167 - Comorbidity Is Associated with Greater Decrements in Quality of Life over Two Years in MS
03:00 PM - 07:30 PM	Abstract	168 - Perceived Cognitive Impairment in Multiple Sclerosis Predicts Quality of Life Independently of Depression
03:00 PM - 07:30 PM	Abstract	169 - Improvement in EDSS Corresponds with Improvement in Quality of Life in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	170 - Longitudinal MRI Assessment of Quality of Life and Disability in Early Treated Relapsing Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	171 - Cognitive Resilience in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	172 - Specific Impairments in the Recognition of Emotional Facial Expressions in Multiple Sclerosis (MS)
03:00 PM - 07:30 PM	Abstract	173 - Physical Comorbidities Are Associated with an Increased Risk of Depression in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	174 - Relationship between Cognitive Performance and Neurological Disability in Early MS
03:00 PM - 07:30 PM	Abstract	175 - Quantifying the Effects of Acute Relapses on Neuropsychological Status in Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	176 - Higher Cognitively Functioning Relapsing-Remitting Multiple Sclerosis Patients Have a More Specific Pattern of Impairment on Neuropsychological Testing
03:00 PM - 07:30 PM	Abstract	177 - Predicting Cognitive Decline in Multiple Sclerosis: Implications for Clinical Trial Design
03:00 PM - 07:30 PM	Abstract	178 - Increased CSF Levels of B Cells Activating Factor (BAFF) in Neuromyelitis Optica (NMO)
03:00 PM - 07:30 PM	Abstract	179 - Intractable Vomiting as the Initial Presentation of Autoimmune Aquaporin-4 Water Channelopathy
03:00 PM - 07:30 PM	Abstract	180 - Effects of Aquaporin4 Antibody in Primary Human Astrocytes in Culture: A Living Cell Imaging Analysis
03:00 PM - 07:30 PM	Abstract	181 - Is NMO a Paraneoplastic Marker?
03:00 PM - 07:30 PM	Abstract	182 - Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroid (CLIPPERS)
03:00 PM - 07:30 PM	Abstract	183 - Can the Increase of T-Helper 17 Lymphocyte Percentage in Peripheral Blood Anticipate a Relapse in Relapsing Remitting Multiple Sclerosis?
03:00 PM - 07:30 PM	Abstract	184 - IL-27 Mediates Glatiramer Acetate Effect on Antigen Presenting Cells in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	185 - Differential Diagnosis of Adult Leucoencephalopathies: Validation of MR Criteria in a Series of 75 Patients
03:00 PM - 07:30 PM	Abstract	186 - Consistent Efficacy of Cladribine Tablets across Multiple Sclerosis and Patient Characteristics, in the Double-Blind, 96-Week CLARITY Study
03:00 PM - 07:30 PM	Abstract	187 - Mitochondrial Disease Manifesting as Multiple Sclerosis: A Report of Two Patients with Optic Neuropathy, Brain White Matter Abnormalities, Cerebrospinal Fluid Oligoclonal Bands, and Novel POLG1 Variations
03:00 PM - 07:30 PM	Abstract	188 - Increased Serum Matrix Metalloproteinase-9 in Neuromyelitis Optica; Implication of Disruption of Blood-Brain Barrier
03:00 PM - 07:30 PM	Abstract	189 - Neuromyelitis Optica in France: A Multicenter Study of 125 Patients
03:00 PM - 07:30 PM	Abstract	190 - Predictive Role of Neuromyelitis Optica (NMO)-IgG in Isolated Optic Neuritis and Isolated Myelitis in the Diagnosis of NMO
03:00 PM - 07:30 PM	Abstract	191 - Anti-Aquaporin 4 Antibodies Increase Transiently after Rituximab Treatment in Neuromyelitis Optica with an Association of B Cell Activating Factor
03:00 PM - 07:30 PM	Abstract	192 - Unconventionnal Spinal Cord and Brain MRI in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	193 - Painful Tonic Spasm in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	194 - Interferon-[beta]1b Increases Th2 Response in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	195 - Chitinase Effects on Immune Cell Responses in Multiple Sclerosis and Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	196 - Neuropsychiatric Presentation of Neuromyelitis Optica Spectrum Disorders
03:00 PM - 07:30 PM	Abstract	197 - Comparison of Type I Interferon Activity in Patients with Systemic Lupus and Neuromyelitis Optica Attachments: View as Web P Comparison of Type I Interferon Activity in Patients with Systemic Lupus and Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	198 - Tumefactive Supraspinal Variant of Severe Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	199 - Mithocondrial DNA Signature in Chronic Inflammatory Diseases of the Central Nervous System
03:00 PM - 07:30 PM	Abstract	200 - Hiccup, Nausea and Vomiting: Neuromyelitis Optica in a Teenage Girl
03:00 PM - 07:30 PM	Abstract	201 - Coexistence of Anti-NMO IgG and Anti-GFAP in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	202 - Evaluation of Health-Related Quality of Life, Fatigue and Depression in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	203 - Early Diagnostic Biomarker in Patients with First Neurological Manifestation Suggestive of Multiple Sclerosis or Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	204 - Severe Relapse Despite B-Cell Depletion in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	205 - Fulminant Neuromyelitis Optica Associated with Human Papilloma Virus Vaccination
03:00 PM - 07:30 PM	Abstract	206 - Case-Report: High-Dose Immunoablation with Autologous Stem Cells Transplantation in Neuromyelitis Optica
03:00 PM - 07:30 PM	Abstract	207 - Antiacquaporin 4 Antibodies Detection in Neuromyelitis Optica (NMO) Patients
03:00 PM - 07:30 PM	Abstract	208 - Coverage of Epilepsy and Driving in US Newspapers
03:00 PM - 07:30 PM	Abstract	209 - Perceptions of Epilepsy at Mulago Hospital in Kampala, Uganda
03:00 PM - 07:30 PM	Abstract	210 - Treatment Continuation Patterns, Resource Use, and Costs among Patients with Epilepsy in a Medicaid Population
03:00 PM - 07:30 PM	Abstract	211 - The Epilepsy Treatment Gap in the Ecuadorian Amazon
03:00 PM - 07:30 PM	Abstract	212 - Assessing the Value of a Medical Home for Children and Youth with Epilepsy in Medically Underserved and Rural Populations
03:00 PM - 07:30 PM	Abstract	213 - A Study on the Change of Quality of Life in People with Epilepsy after 2-Year Follow-Up
03:00 PM - 07:30 PM	Abstract	214 - Do Mood Instability Symptoms in Epilepsy Represent Formal Bipolar Disorder?
03:00 PM - 07:30 PM	Abstract	215 - Health Anxiety and Somatic Vigilance in Epilepsy and Non-Epileptic Behavioral Spells
03:00 PM - 07:30 PM	Abstract	216 - Oro-Dental and Maxillofacial Trauma in Epilepsy: Our Experience at a Tertiary Hospital in Lagos
03:00 PM - 07:30 PM	Abstract	217 - Spinal Cord Compression: A Potential Risk in Individuals with Mental Retardation and Epilepsy
03:00 PM - 07:30 PM	Abstract	218 - Rapid Screening for Anxiety and Major Depressive Disorders and Suicidal Risk in an Outpatient Neurology Clinic
03:00 PM - 07:30 PM	Abstract	220 - Fatigue in People with Epilepsy. The Validation of the Fatigue Symptom Inventory, the Fatigue Assessment Instrument and the Fatigue Severity Scale in Patients with Epilepsy
03:00 PM - 07:30 PM	Abstract	221 - MERRF: Clinical Features, Muscle Biopsy and Molecular Genetics
03:00 PM - 07:30 PM	Abstract	222 - Frequency and Correlates of Perceived Stigma in a Nigerian Epilepsy Population
03:00 PM - 07:30 PM	Abstract	223 - Early Seizures after Discharge from a Seizure Monitoring Unit
03:00 PM - 07:30 PM	Abstract	224 - Effect of Pregnancy on Seizure Frequency in Women with Epilepsy
03:00 PM - 07:30 PM	Abstract	225 - Inadequate Vitamin D Levels in Pediatric Patients with Epilepsy
03:00 PM - 07:30 PM	Abstract	226 - Recurrent Status Epilepticus as the Primary Neurological Manifestation of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL): A Case Report
03:00 PM - 07:30 PM	Abstract	227 - Mycophenolate Mofetil Responsive Anti-Glutamic Acid Decarboxylase Antibody Associated Limbic Encephalitis
03:00 PM - 07:30 PM	Abstract	228 - Computerized Dynamic Posturography [CDP] Identifies an Early Sub-Clinical Balance Disorder in Amyotrophic Lateral Sclerosis (ALS) Patients Not Diagnosed by Clinical Balance Assessment
03:00 PM - 07:30 PM	Abstract	229 - Detecting Disordered Sleep in Patients with ALS: Results of a 10-Minute Targeted Sleep Questionnaire
03:00 PM - 07:30 PM	Abstract	230 - Validation of a Shorter ALS-Specific Quality of Life Instrument: The ALSSQOL-R
03:00 PM - 07:30 PM	Abstract	231 - Prospective Study of Depression, ALS-Related Symptoms, and Research Enrollment
03:00 PM - 07:30 PM	Abstract	232 - Utility of Forced Expiratory Volume in 6 Seconds for Assessment of Respiratory Function in Patients with Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM	Abstract	233 - Plasma Levels of Neurofilament Heavy Subunit (NF-H) Are Increased in ALS Patients; Correlation with Site of Onset and Survival in Patients at 2 Centers in Evaluation of Plasma NF-H as a Potential ALS Biomarker
03:00 PM - 07:30 PM	Abstract	234 - Effects of Non-Invasive Ventilation on Sleep Outcomes in Patients with Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM	Abstract	235 - Muscle Ultrasound Quantifies Reduction of Muscle Thickness over Time in ALS Patients
03:00 PM - 07:30 PM	Abstract	236 - Using Eye Movements To Distinguish Amyotrophic Lateral Sclerosis (ALS) from Its Variants and Mimics
03:00 PM - 07:30 PM	Abstract	237 - The Prevalence and Effect of Diabetes on the Course of Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM	Abstract	238 - Evidence for a Decreased Activity of the Resting State Motor Network in Patients with ALS
03:00 PM - 07:30 PM	Abstract	239 - Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients
03:00 PM - 07:30 PM	Abstract	240 - 15-30 Hz Intermuscular Coherence: A Novel Biomarker of Upper Motor Neurone Dysfunction in Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM	Abstract	241 - Baseline and Longitudinal Perspectives on Motor Cortex Grey and White Matter in ALS
03:00 PM - 07:30 PM	Abstract	242 - Slow Saccades in Bulbar-Onset Amyotrophic Lateral Sclerosis (ALS)
03:00 PM - 07:30 PM	Abstract	243 - Assessment of CSF Biomarkers in a Pilot Study of Memantine in ALS
03:00 PM - 07:30 PM	Abstract	244 - Nutritional Prognostic Factors in Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM	Abstract	245 - Shoulder Pain in ALS
03:00 PM - 07:30 PM	Abstract	246 - Oral Secretion Scale [OSS] Score in Amyotrophic Lateral Sclerosis[ALS] Patients Is Associated with Tolerance of Noninvasive Positive Pressure Ventilation [NPPV], Need for Hospice or Transition to Tracheal Positive Pressure Ventilation [TPPV] and Survival
03:00 PM - 07:30 PM	Abstract	247 - Maternally Inherited Limb-Girdle Myopathy with Neck Extensor and Cardiopulmonary Involvement Resulting from a Mitochondrial tRNA Leu3302 Point Mutation
03:00 PM - 07:30 PM	Abstract	248 - A Novel Mitochondrial tRNAIle Mutation Uniquely Affecting the Variable Loop in a Patient with Chronic Progressive External Ophthalmoplegia (CPEO)
03:00 PM - 07:30 PM	Abstract	249 - Clinical and Molecular Characterization of the MERRF Mutation A8344G in a Family without CNS Involvement
03:00 PM - 07:30 PM	Abstract	250 - Diverse Clinical Presentations in Adults with Carnitine Deficiency
03:00 PM - 07:30 PM	Abstract	251 - Mitoshondrial Myopathy, a Rare or a Common Human Disease? Based on Nation-Wide MELAS Cohort Study
03:00 PM - 07:30 PM	Abstract	252 - Cardiofaciocutaneous Syndrome Due to BRAF Mutation Causes CoQ10 Myopathy
03:00 PM - 07:30 PM	Abstract	253 - Relapsing Encephalopathy Associated with Coenzyme Q10 Deficiency
03:00 PM - 07:30 PM	Abstract	254 - A Prospective Randomized Double-Blind and Placebo Controlled Phase II Trial - Effect of CoQ 10 on Statin Induced Mitochondrial Dysfunction
03:00 PM - 07:30 PM	Abstract	255 - Acquired and Environmental Mitochondrial Toxicity in Patients with Adult-Onset Chronic Progressive External Ophthalmoplegia
03:00 PM - 07:30 PM	Abstract	256 - Incidental Mitochondrial Myopathy
03:00 PM - 07:30 PM	Abstract	257 - Genetic Markers for CK Outliers in Army Recruits; Relationship to Exertional Rhabdomyolysis?
03:00 PM - 07:30 PM	Abstract	258 - Clinicopathological Features of Patients with Dermatomyositis with Subcutaneous Edema
03:00 PM - 07:30 PM	Abstract	259 - Autoimmune Myopathy without Inflammation (AMWI); Clinical and Laboratory Features
03:00 PM - 07:30 PM	Abstract	260 - Sporadic Inclusion Body Myositis: Evaluation of 116 Cases
03:00 PM - 07:30 PM	Abstract	261 - Amyloid Myopathy: A Diagnostic Dilemma
03:00 PM - 07:30 PM	Abstract	262 - Electromyography in Dropped Head Syndrome Following Remote Radiation
03:00 PM - 07:30 PM	Abstract	263 - Prevalence and Risk Factors of Muscular Complications among Patients Using Statins
03:00 PM - 07:30 PM	Abstract	264 - Myopathy Developed during Clevudine Therapy
03:00 PM - 07:30 PM	Abstract	265 - Acetazolamide-Induced Recurrent Paralysis
03:00 PM - 07:30 PM	Abstract	266 - Characterization of Electrophysiological Findings in 55 Patients with Biopsy-Proven Critical Illness Myopathy
03:00 PM - 07:30 PM	Abstract	267 - Psychometric Evaluation of the Short Form 36 and Individualised Neuromuscular Quality of Life (INQoL) Questionnaire Domains in Patients with Muscle Disease and Myasthenia Gravis (MG)
03:00 PM - 07:30 PM	Abstract	268 - Ethical and Social Challenges in Healthcare for Adolescents and Young Adults with Cerebral Palsy
03:00 PM - 07:30 PM	Abstract	269 - Experience and Attitudes of Healthcare Professionals Regarding Ethics Issues and End-of-Life Decision Making in Patients Suffering from Chronic Disorders of Consciousness
03:00 PM - 07:30 PM	Abstract	270 - Hope and Patient Expectation in Deep Brain Stimulation (DBS): Healthcare Provider Perspectives and Approaches
03:00 PM - 07:30 PM	Abstract	271 - Euthanasia in Patients Suffering from Dementia: Patient-Oriented Ethical Approach
03:00 PM - 07:30 PM	Abstract	272 - Quantitative Assessment of the Pain Disability in Individuals with Nervous System Disorders Due to Polytrauma, According to the AMA Guides to Evaluation of Permanent Impairment Fifth Edition
03:00 PM - 07:30 PM	Abstract	273 - Worsening of Fibromyalgia Symptoms Following Abrupt Discontinuation of Milnacipran: Results from a Randomized, Double-Blind, Placebo-Controlled Trial
03:00 PM - 07:30 PM	Abstract	274 - The Efficacy and Tolerability of Milnacipran 100 mg/day Monotherapy for the Management of Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
03:00 PM - 07:30 PM	Abstract	275 - A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Trial of Intradermal Onabotulinumtoxin A Injections in the Treatment of Post Herpetic Neuralgia (PHN)
03:00 PM - 07:30 PM	Abstract	276 - Efficacy and Safety of Long-Term Lidocaine Trigger Point Injections in Patients with Chronic Musculoskeletal Pain
03:00 PM - 07:30 PM	Abstract	277 - Ethical Challenges Encountered in an Experimental Research Protocol for Rabies Encephalitis
03:00 PM - 07:30 PM	Abstract	278 - Palliative Care in Neurological Catastrophes: Guidelines for System Specific Supportive Care
03:00 PM - 07:30 PM	Abstract	279 - The Enigma of a Chronic Pain Syndrome [mdash] A High Level of Diagnostic Suspicion, Vigilance and Close Follow-Up Sometimes Results in an Alternative Diagnosis (Acute Intermittent Porphyria)
03:00 PM - 07:30 PM	Abstract	280 - A Randomized, Crossover Polysomnography Study of Gabapentin Enacarbil in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome and Associated Sleep Disturbance
03:00 PM - 07:30 PM	Abstract	281 - An Open-Label, 52-Week Extension Study To Assess the Long-Term Tolerability and Efficacy of Gabapentin Enacarbil in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome
03:00 PM - 07:30 PM	Abstract	282 - Population Pharmacokinetics and Pharmacodynamics of Gabapentin after Administration of Gabapentin Enacarbil in Subjects with Primary Restless Legs Syndrome
03:00 PM - 07:30 PM	Abstract	283 - Gabapentin Enacarbil Improves RLS Symptoms and Subjective Measures of Sleep in Subjects with Primary Restless Legs Syndrome with and without Severe Sleep Disturbance: Secondary Analyses from Two Studies
03:00 PM - 07:30 PM	Abstract	284 - Gabapentin Enacarbil Relieves the Pain Associated with Restless Legs Syndrome
03:00 PM - 07:30 PM	Abstract	285 - An Examination of Mood, Quality of Life, and Function in Subjects with Primary Restless Legs Syndrome (RLS) Treated with Gabapentin Enacarbil Compared with Placebo
03:00 PM - 07:30 PM	Abstract	286 - Evaluating Maintenance of Improvements in Sleep and Quality of Life in Subjects with Restless Legs Syndrome Treated with Gabapentin Enacarbil for up to 36 Weeks
03:00 PM - 07:30 PM	Abstract	287 - An Evaluation of Gabapentin Enacarbil and Restless Legs Syndrome Symptom Augmentation in Subjects Treated for 12 Weeks: Secondary Analyses from Two Studies
03:00 PM - 07:30 PM	Abstract	288 - Augmentation during Treatment with Ropinirole in Restless Legs Syndrome. Results from a Prospective, Multicentric Study over Sixty-Six Weeks
03:00 PM - 07:30 PM	Abstract	289 - Neuroanatomical Aspect of the Diencephalospinal Dopaminergic Pathway in the Non Human Primate: Potential Implications for the Restless Legs Syndrome
03:00 PM - 07:30 PM	Abstract	290 - Proteomic Analysis of the Cerebrospinal Fluid of Patients with Restless Legs Syndrome
03:00 PM - 07:30 PM	Abstract	291 - A New Locus for Familial Restless Legs Syndrome on Chromosome 21 in a Large Utah Kindred
03:00 PM - 07:30 PM	Abstract	292 - Cardiopulmonary Fitness is Associated with Cognitive Performance in Patients with Coronary Artery Disease

Faculty Disclosures
Robert E. Hogan, MD	Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.
Randolph B. Schiffer, MD	No disclosure on file
James L. Bernat, MD, F�鶹��ýӳ��	Dr. Bernat has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Physician's Index for Ethics in Medicine. The institution of Dr. Bernat has received research support from National Institutes of Health UL1TR001086. The institution of Dr. Bernat has received research support from National Institutes of Health ME-1609-36174. Dr. Bernat has received publishing royalties from a publication relating to health care.
Robert L. Ruff, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Mark Keegan, MD, F�鶹��ýӳ��	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Zachary Simmons, MD, F�鶹��ýӳ��	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
William W. Campbell, MD, MSHA, F�鶹��ýӳ��	No disclosure on file
	No disclosure on file
Robert P. Bowser, PhD	An immediate family member of Dr. Bowser has received personal compensation for serving as an employee of nVector, Inc.. Dr. Bowser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MT Pharma USA. Dr. Bowser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Therapeutics. Dr. Bowser has or had stock in nVector.Dr. Bowser has received intellectual property interests from a discovery or technology relating to health care.
Emma R. Burbank, MD	No disclosure on file
Jeffrey L. Cummings, MD, F�鶹��ýӳ��	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Randall Kaye, MD	No disclosure on file
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Arthur S. Walters, MD, F�鶹��ýӳ��	No disclosure on file
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
A. M. Barrett, MD, F�鶹��ýӳ��	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Matthew P. Wicklund, MD, F�鶹��ýӳ��	Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Benjamin R. Brooks, MD, F�鶹��ýӳ��	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities.
Nader N. Antonios, MD	No disclosure on file
Jeffrey Bigelow, MD	No disclosure on file
Adrian J. Hepner, MD	No disclosure on file
Ahmad Bayrlee, MD	No disclosure on file
Catherine A. Belin, MD	No disclosure on file
Antoine F. Carpentier	No disclosure on file
Roberto Cavallo, MD	No disclosure on file
Tiffany W. Chow, MD, F�鶹��ýӳ��	Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.
Gene L. Bowman, ND	No disclosure on file
Afshin A. Divani, PhD	The institution of Dr. Divani has received research support from Department of Defense.
Luca Durelli, MD	No disclosure on file
Lauren B. Elman, MD	Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Sung Hyuk Heo, MD	No disclosure on file
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Morris Freedman, MD, F�鶹��ýӳ��	No disclosure on file
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical �鶹��ýӳ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' �鶹��ýӳ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical �鶹��ýӳ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research �鶹��ýӳ�� Social Awareness and Training In Neurosciences.
Daniel R. Wynn, MD	Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to �鶹��ýӳ�� interests or activities.
Antonio Bertolotto, MD, F�鶹��ýӳ��	Dr. Bertolotto has nothing to disclose.
Sandra E. Black, MD, F�鶹��ýӳ��	Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Paola Cavalla	No disclosure on file
S. A. Josephson, MD, F�鶹��ýӳ��	Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Joseph F. Quinn, MD, F�鶹��ýӳ��	Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to �鶹��ýӳ�� interests or activities.
Lauren Reoma, MD, F�鶹��ýӳ��	Dr. Reoma has received research support from NIH. Dr. Reoma has a non-compensated relationship as a Vice Chair with �鶹��ýӳ�� Experimental Neurotherapeutics Section that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reoma has a non-compensated relationship as a Federal Employee with NINDS/NIH that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reoma has a non-compensated relationship as a Member with ASENT Program Committee that is relevant to �鶹��ýӳ�� interests or activities.
J. Javier Provencio, MD, F�鶹��ýӳ��	Dr. Provencio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minnetronix. The institution of Dr. Provencio has received research support from NIH NINDS.
Marco Capobianco, MD	No disclosure on file
Erik P. Pioro, MD, DPhil, F�鶹��ýӳ��	Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Vanja C. Douglas, MD, F�鶹��ýӳ��	Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Anne-Marie Ergis	No disclosure on file
Catherine C. Ikard, MD	Dr. Ikard has nothing to disclose.
Khalid I. El-Salem, MD, F�鶹��ýӳ��	Dr. El-Salem has nothing to disclose.
Julene K. Johnson	No disclosure on file
Lisa Johnston, MD	No disclosure on file
Danae Lariviere-Bastien	No disclosure on file
Kenneth Cundy, PhD	No disclosure on file
Rozalina Dimitrova, MD, MPH	No disclosure on file
Sinead Jordan	Sinead Jordan has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Idec.
Ritu Lal, PhD	No disclosure on file
Giulia Contessa	No disclosure on file
Anne H. Cross, MD, F�鶹��ýӳ��	Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Deepali Y. Jain, MD, MBBS	Dr. Jain has nothing to disclose.
Ali H. Alrefai, MD	No disclosure on file
Jeffrey J. Bazarian, MD	Dr. Bazarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbott. Dr. Bazarian has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BioMerieux. The institution of Dr. Bazarian has received research support from BrainBox Solutions. The institution of Dr. Bazarian has received research support from Abbott.
Tamara Castillo-Trivino, MD, MAS, F�鶹��ýӳ��	Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Dae-Il Chang, MD	No disclosure on file
Anna D. Hohler, MD, F�鶹��ýӳ��	Dr. Hohler has nothing to disclose.
Daniel Lee, MD, F�鶹��ýӳ��	No disclosure on file
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Jan Debruyne, MD, PhD	No disclosure on file
Neetu Dhadwal, MD	No disclosure on file
Alessia Di Sapio, MD	No disclosure on file
Frances M. Dyro, MD, F�鶹��ýӳ��	No disclosure on file
Mihaela F. Hangan, MD	No disclosure on file
Michal Kral	No disclosure on file
Michael Kruer, MD	Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
Haralambos Alexopoulos	No disclosure on file
Zaid Al-Qudah, MD	No disclosure on file
Miguel Chuquilin Arista, MD, F�鶹��ýӳ��	Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item writer with �鶹��ýӳ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with �鶹��ýӳ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with �鶹��ýӳ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item reviewer with National Board of Medical Examiners. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Southeast regional advisory board with Argenx. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Focus group with Alexion. Dr. Chuquilin Arista has received personal compensation in the range of $0-$499 for serving as a Speaker with Periodic Paralysis Association.
Jeffrey A. Kaye, MD, F�鶹��ýӳ��	Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Keith Sanders, MD, F�鶹��ýӳ��	Dr. Sanders has nothing to disclose.
Tae B. Ahn, MD	No disclosure on file
Evica Dincic, MD, PhD	No disclosure on file
Thomas J. Grabowski, MD	The institution of Dr. Grabowski has received research support from NIH.
Erwan Bezard, PhD	Dr. Bezard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Treefrog Therapeutics. Dr. Bezard has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurobiology of Disease (Elsevier). Dr. Bezard has stock in Motac neuroscience. Dr. Bezard has stock in Treefrog Therapeutics. Dr. Bezard has stock in SE Therapeutics. The institution of Dr. Bezard has received research support from European Research Council. The institution of Dr. Bezard has received research support from Agence Nationale de la Recherche. The institution of Dr. Bezard has received research support from Michael J Fox Foundation. Dr. Bezard has received intellectual property interests from a discovery or technology relating to health care.
Claudio Gasperini, MD	Dr. Gasperini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche, Merck, Genzyme, Novartis,Bayer, Teva, Almirall.
Anat Achiron, MD, PhD, F�鶹��ýӳ��	Dr. Achiron has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, F�鶹��ýӳ��	Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Ioanna Chatzi	No disclosure on file
Peter Kanovsky	No disclosure on file
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Eva Krasulova, MD	No disclosure on file
Allen J. Aksamit, Jr., MD, F�鶹��ýӳ��	Dr. Aksamit has nothing to disclose.
Mitchell F. Brin, MD, F�鶹��ýӳ��	Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Sherry Hsiang-Yi Chou, MD	Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to �鶹��ýӳ�� interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to �鶹��ýӳ�� interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to �鶹��ýӳ�� interests or activities.
Fernando Cendes, MD, PhD, F�鶹��ýӳ��	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Athanasia Alexoudi, MD	Dr. Alexoudi has nothing to disclose.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Emily Bell, PhD	No disclosure on file
James D. Bowen, MD	Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Francesca Gilli	No disclosure on file
James P. Kesslak, PhD	Dr. Kesslak has received personal compensation for serving as an employee of Alzheon.
Karl Krecke	Karl Krecke has nothing to disclose.
Reza Seyedsadjadi, MD	Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation.
Nereo Bresolin, DR	No disclosure on file
Kyung-Cheon Chung, MD	No disclosure on file
J. Clay Goodman, MD, F�鶹��ýӳ��	Dr. Goodman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology (ABPN). The institution of an immediate family member of Dr. Goodman has received research support from NIH.
Jose Balseiro	No disclosure on file
Stefano Bastianello	No disclosure on file
Deborah Y. Bradshaw, MD, F�鶹��ýӳ��	The institution of Dr. Bradshaw has received research support from Alexion. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Margaret Brickley, NP	No disclosure on file
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Islam M. Abujubara, MD	No disclosure on file
Mathew Alexander, MD	No disclosure on file
Raeburn B. Forbes, MD(Hons)	No disclosure on file
Maria Goicochea	No disclosure on file
David A. Chad, MD, F�鶹��ýӳ��	No disclosure on file
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Ronald Barrett	No disclosure on file
Achim Berthele, MD	No disclosure on file
Frederic Blanc	No disclosure on file
Nabila Choudhury	No disclosure on file
Marcio L. Balthazar, MD, PhD	No disclosure on file
Valentina Durastanti, MD	No disclosure on file
Sunil K. Goli, MD	No disclosure on file
Marie Fleury	No disclosure on file
Andrew Godbey, MD	No disclosure on file
Steven E. Arnold, MD	Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon.
Dan J. Capampangan, MD, F�鶹��ýӳ��	No disclosure on file
Benito P. Damasceno, MD, PhD	No disclosure on file
Sudeepta Dandapat, MD	Dr. Dandapat has nothing to disclose.
Eliahu S. Feen, MD	No disclosure on file
Andrew M. Blumenfeld, MD, F�鶹��ýӳ��	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Isaac Annan, MD	No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, F�鶹��ýӳ��	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Georgia Dokou	No disclosure on file
Glen M. Doniger, PhD	No disclosure on file
Michael B. Fawale, MBBS, MSc, FMCP	No disclosure on file
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Enrico Millefiorini	No disclosure on file
Luigi Maria Grimaldi, MD	No disclosure on file
Patrick Cras, MD, PhD	The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee.
R E. Faught, Jr., MD, F�鶹��ýӳ��	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Anil K. Nair, MD, F�鶹��ýӳ��	No disclosure on file
Peter D. Donofrio, MD, F�鶹��ýӳ��	No disclosure on file
Maria I. Aguilar, MD	Dr. Aguilar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech.
Pamela A. Cazzolli, RN	No disclosure on file
Ding Ding, MD, MPH	No disclosure on file
Julie A. Khoury, MD	Dr. Khoury has nothing to disclose.
Yitao Ma, MD	Dr. Ma has nothing to disclose.
Imke Metz	No disclosure on file
Myung-Goo Ji, MD	No disclosure on file
George H. Kraft, MD	No disclosure on file
Shahram Gharibshahi, MD	No disclosure on file
Susanne Grafe, MD	No disclosure on file
Augusto Grinspan, MD	Dr. Grinspan has received personal compensation for serving as an employee of Insightec.
Nicole C. Hank, MCR, MHSM	No disclosure on file
Richard J. Riopelle, MD	No disclosure on file
Swati Sathe, MD	Dr. Sathe has received personal compensation in the range of $0-$499 for serving as a Expert opinion with FirstThought.IO.
Simona Malucchi	No disclosure on file
Petr Hlustik, MD, PhD	The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Kimbra L. Kenney, MD, F�鶹��ýӳ��	Dr. Kenney has nothing to disclose.
Maria Lukasik, MD, PhD	No disclosure on file
Leopold Liss, MD	No disclosure on file
Marcela Fiol	Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. The institution of Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Julian Benito-Leon	No disclosure on file
Miroslaw Brys, MD, PhD	No disclosure on file
Samuel A. Frank, MD, F�鶹��ýӳ��	Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
Zhen Hong, MD	No disclosure on file
Louisa Lavy, MD	No disclosure on file
Mei Lu, MD	No disclosure on file
Brian E. McGeeney, MD	No disclosure on file
Roy H. Hamilton, MD, MS, FANA, F�鶹��ýӳ��	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Stephen Mathew, MBBS	No disclosure on file
James A. Mortimer, PhD, F�鶹��ýӳ��	No disclosure on file
Stephen S. Johnston, MA	No disclosure on file
Edward Kim, MD	Dr. Kim has nothing to disclose.
Wojciech Kozubski, MD, PhD	No disclosure on file
Bruce R. Krueger, MD	No disclosure on file
Petra Minnasch, MD	No disclosure on file
Panagiota Filippakopoulou	No disclosure on file
Kazuo Fujihara, MD	Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Anita L. Belman, MD, F�鶹��ýӳ��	No disclosure on file
Salvatore Cottone, MD	No disclosure on file
Marcos C. Fernandez Suarez, MD	No disclosure on file
Maria Gaitan, MD	Dr. Gaitan has nothing to disclose.
Ludwig Gutmann, MD, F�鶹��ýӳ��	Dr. Gutmann has a non-compensated relationship as a senior consulting editor (Humanities) with NEUROLOGY that is relevant to �鶹��ýӳ�� interests or activities.
Bahareh Hassanzadeh, MD	Dr. Hassanzadeh has nothing to disclose.
Anica Law	No disclosure on file
Nancy Maalouf, MD	No disclosure on file
Simon Mead	No disclosure on file
Tatsuro Misu	No disclosure on file
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Naim I. Haddad, MD, F�鶹��ýӳ��	Dr. Haddad has nothing to disclose.
Yasutoshi Koga, MD, PhD	No disclosure on file
Jin Li, MD, PhD, F�鶹��ýӳ��	Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities.
Renato P. Munhoz, MD, PhD	Dr. Munhoz has nothing to disclose.
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
S H. Subramony, MBBS, F�鶹��ýӳ��	Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex. The institution of Dr. Subramony has received research support from Sanofi.
Andreas R. Luft, MD	No disclosure on file
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Siu-Hin Wan	No disclosure on file
Oded Abramsky, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Ann M. Bergin, MD	No disclosure on file
Andrew H. Chan, MD	No disclosure on file
Shu-Ing Chang	No disclosure on file
Pierre Clavelou, MD, PhD	Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Bertha C. Ekeh, MD	No disclosure on file
Peter A. Michas-Martin, MD	No disclosure on file
Priya A. Monrad, MD	No disclosure on file
Hideto Nakajima, MD	No disclosure on file
Dominick Paes	No disclosure on file
Yuko Palesch	No disclosure on file
Daniel Sanak	No disclosure on file
Irena Pulte	Irena Pulte has received personal compensation for serving as an employee of Merz Pharmaceuticals . Irena Pulte has received intellectual property interests from a discovery or technology relating to health care.
Catherine Rodrigue	No disclosure on file
Elizabeth A. Shuster, MD	No disclosure on file
Roisin Lonergan, MD	No disclosure on file
Barbara C. Jobst, MD, PhD, F�鶹��ýӳ��	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Henry J. Kaminski, MD, F�鶹��ýӳ��	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Petra Nytrova	No disclosure on file
Nataliya Povalko, MD, PhD	No disclosure on file
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
Cedric S. Raine, PhD, DSc	No disclosure on file
Michael R. Rose, MD	No disclosure on file
William Jagust, MD	No disclosure on file
Appaji Rayi, MD, F�鶹��ýӳ��	Dr. Rayi has nothing to disclose.
Patricia M. Riccio, MD	No disclosure on file
Jeronimo Rodriguez, MD, F�鶹��ýӳ��	No disclosure on file
Lampros Samartzis, MD	No disclosure on file
Judith Stephenson	No disclosure on file
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Christine Caivano, PharmD	No disclosure on file
Stephanie Jurgensen, PhD	No disclosure on file
Deborah McGruder, MPH	No disclosure on file
Sinead M. Murphy, MD	Dr. Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Murphy has received research support from Genomics Medicine Ireland. The institution of Dr. Murphy has received research support from Novartis.
Michele Perini, MD	No disclosure on file
Alan Pestronk, MD, F�鶹��ýӳ��	The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Susanna Shepper, MD	No disclosure on file
Stephen M. Wilson, PhD	No disclosure on file
Charles Wira	Charles Wira has nothing to disclose.
Claudia F. Lucchinetti, MD, F�鶹��ýӳ��	The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to �鶹��ýӳ�� interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to �鶹��ýӳ�� interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to �鶹��ýӳ�� interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to �鶹��ýӳ�� interests or activities.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Jonathan D. Glass, MD	Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.
Aissatou Haman	No disclosure on file
Caryn Harper	No disclosure on file
William T. Hu, MD, PhD, F�鶹��ýӳ��	Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Peterkin Lee Kwen, MD	No disclosure on file
Richard Leigh, MD	The institution of Dr. Leigh has received research support from National Institutes of Health. The institution of Dr. Leigh has received research support from American Heart Association. Dr. Leigh has received intellectual property interests from a discovery or technology relating to health care.
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Catherine Lomen-Hoerth, MD, PhD, F�鶹��ýӳ��	Dr. Lomen-Hoerth has nothing to disclose.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Adam Carpenter, MD	An immediate family member of Dr. Carpenter has received personal compensation for serving as an employee of MarPam Pharma. The institution of Dr. Carpenter has received research support from Roche. The institution of Dr. Carpenter has received research support from Immune Tolerance Network. The institution of an immediate family member of Dr. Carpenter has received research support from NIH.
Aiden Haghikia, MD	Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Leo McCluskey, MD	No disclosure on file
Robert G. Miller, MD	The institution of Dr. Miller has received research support from Nurown.
Preeti Puntambekar, MD	Dr. Puntambekar has nothing to disclose.
Srijana Zarkou, MD	Dr. Zarkou has nothing to disclose.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Indrani Acosta, MD	No disclosure on file
Eduardo Garcia, MD, F�鶹��ýӳ��	Dr. Garcia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for United Diagnostics .
Paul Golumbek, MD, PhD	No disclosure on file
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Clete A. Kushida, MD, PhD	Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Rolf Martin	No disclosure on file
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Jack H. Simon, MD, PhD	No disclosure on file
Yuen T. So, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Paola Valsasina	Paola Valsasina has nothing to disclose.
Christophe Hotermans, MD, PhD	No disclosure on file
Marcelo Matiello, MD, F�鶹��ýӳ��	Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.
Til Menge, MD, F�鶹��ýӳ��	No disclosure on file
Michelle M. Mezei, MD	No disclosure on file
Tomas Olsson, MD, PhD	Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Olsson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Prof. Olsson has received research support from Biogen. The institution of Prof. Olsson has received research support from Novartis. The institution of Prof. Olsson has received research support from Sanofi. The institution of Prof. Olsson has received research support from Merck.
Mary R. Rensel, MD, F�鶹��ýӳ��	Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Douglas W. Scharre, MD, F�鶹��ýӳ��	Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Mary Beth E. Toran, MD	No disclosure on file
Adi Vaknin-Dembinsky, MD	No disclosure on file
Matthew Warner	No disclosure on file
Chidam M. Yegappan, MD, MBBS	No disclosure on file
John W. Lindsey, MD	Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Sandra Morovic, MD, PhD	No disclosure on file
A T. Perkins, MD, PhD	No disclosure on file
James W. Schmidley, MD	No disclosure on file
Monica Sciacco, MD	No disclosure on file
Robert J. Fox, MD, F�鶹��ýӳ��	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Samir Belagaje, MD, F�鶹��ýӳ��	Dr. Belagaje has nothing to disclose.
Domenico Caputo, MD	No disclosure on file
Khosro Farhad, MD, F�鶹��ýӳ��	Dr. Farhad has nothing to disclose.
Murray S. Flaster, MD, PhD	No disclosure on file
Benjamin P. George, MD	Dr. George has nothing to disclose.
Olivier F. Gout, MD	Dr. Gout has nothing to disclose.
Zeenat Jaisani, MD	Dr. Jaisani has nothing to disclose.
Seema R. Khurana	Seema R. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pirmal.
Amy Kuo	No disclosure on file
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Daune L. MacGregor, MD, F�鶹��ýӳ��	No disclosure on file
Axel Methner, MD	No disclosure on file
James A. Russell, DO, F�鶹��ýӳ��	Dr. Russell has received publishing royalties from a publication relating to health care.
Parampreet Singh, MD	No disclosure on file
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Sylvie Allouche, MD	No disclosure on file
Michael Phipps, MD, MHS, F�鶹��ýӳ��	Dr. Phipps has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMJ.
Stephen M. Rao, PhD	No disclosure on file
Kinshuk Sahaya, MD, FAES, F�鶹��ýӳ��	Dr. Sahaya has nothing to disclose.
Shiv Saidha, MD	Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Claire Riley, MD, F�鶹��ýӳ��	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
R B. Sommerville, MD	No disclosure on file
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Giovanni Castelnovo	No disclosure on file
Hans-Peter Hartung, MD, F�鶹��ýӳ��	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Xavier Montalban, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Richard A. Rudick, MD, F�鶹��ýӳ��	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Merit E. Cudkowicz, MD, MSC, F�鶹��ýӳ��	Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Richard P. Allen, PhD	No disclosure on file
Lesley M. Arnold, MD	No disclosure on file
John Barkenbus, MD	No disclosure on file
Elisabetta Di Monte	No disclosure on file
Tom Gualtieri	No disclosure on file
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Lisa Mucha, PhD	No disclosure on file
Carol Moore	No disclosure on file
David Skoloudik, MD, PhD	No disclosure on file
Luisa Sosso, MD	No disclosure on file
Subramaniam Sriram, MD	Dr. Sriram has nothing to disclose.
Helio Afonso G. Teive, MD, PhD, F�鶹��ýӳ��	Dr. Teive has nothing to disclose.
Michael M. Tuchman, MD, F�鶹��ýӳ��	No disclosure on file
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Ronald S. Black, MD	No disclosure on file
Bruno Brochet, MD, FEAN	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Pasquale Calabrese, PhD	Dr. Calabrese has nothing to disclose.
Heather S. Conklin	No disclosure on file
Alain Creange	Alain Creange has nothing to disclose.
Gilles Edan, MD	No disclosure on file
Anne Caroline Papeix	No disclosure on file
Joshua Pasol, MD	No disclosure on file
Ryan A. Armour, DO	No disclosure on file
Tomislav Breitenfeld, MD, MS	No disclosure on file
Leonardo G. Cohen, MD	The institution of Dr. Cohen has received research support from NIH.
Vida Demarin, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Richard K. Kim, MD	Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Venkat Ramani, MD, F�鶹��ýӳ��	No disclosure on file
Nizar Souayah, MD, F�鶹��ýӳ��	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Avraham Almozlino, MD, F�鶹��ýӳ��	Dr. Almozlino has nothing to disclose.
Timothy J. Counihan, MD, F�鶹��ýӳ��	Dr. Counihan has nothing to disclose.
Karen Fisher	No disclosure on file
Nicolas Gaspard, MD, PhD	The institution of Prof. Gaspard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioserenity. The institution of Prof. Gaspard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. The institution of Prof. Gaspard has received research support from Fonds pour la Recherche Scientifique.
Christina Hill-Zabala, PharmD	No disclosure on file
Agustin Ibanez, PhD	Dr. Ibanez has nothing to disclose.
Paul M. Levisohn, MD	No disclosure on file
Sarah A. Morrow, MD, MSC, FRCPC, F�鶹��ýӳ��	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Yun Qu, MD	No disclosure on file
Nizar Chahin, MD	Dr. Chahin has nothing to disclose.
Alvin Chandra	No disclosure on file
Raveen Deol, MD	No disclosure on file
Susan E. Goelz, PhD	No disclosure on file
Emmanuelle Le Page	Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Lael Stone, MD	No disclosure on file
Haythum O. Tayeb, MD	Dr. Tayeb has nothing to disclose.
Gerardo Tiezzi, MD	No disclosure on file
MingMing Ning, MD	No disclosure on file
Helen E. Stephens	No disclosure on file
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Paul W. O'Connor, MD	No disclosure on file
Noor A. Pirzada, MD, F�鶹��ýӳ��	Dr. Pirzada has nothing to disclose.
Kristina M. Fanning, PhD	The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Bruno Lenne, PhD	No disclosure on file
Yousef Mohammad, MD	No disclosure on file
Reinhold Schmidt, MD	No disclosure on file
Onofre Combarros Pascual	No disclosure on file
Gigliola Fagiolari	No disclosure on file
Franz Fazekas, MD	No disclosure on file
Mark S. Freedman, MD, F�鶹��ýӳ��	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Pietro Iaffaldano	No disclosure on file
Stefano Jann, MD	No disclosure on file
Morenikeji Komolafe, MD	Dr. Komolafe has nothing to disclose.
Marie-Liesse Lassauzet, PhD	No disclosure on file
Enchi Liu, PhD	No disclosure on file
David H. Miller, MD, MBChB, FRCP	No disclosure on file
Chris H. Polman, MD	No disclosure on file
Bappaditya Ray, MD	Dr. Ray has nothing to disclose.
Eloy Rodriguez-Rodriguez	Eloy Rodriguez-Rodriguez has nothing to disclose.
Rosana H. Scola, MD	Dr. Scola has nothing to disclose.
Carlos Silvado, MD	No disclosure on file
Birgit E. Hogl, MD	No disclosure on file
Adil Javed, MD, PhD	The institution of Dr. Javed has received research support from Genentech Roche .
Do Han Kim, MD	No disclosure on file
Jennifer J. Majersik, MD, F�鶹��ýӳ��	Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Francis I. Ojini, MD	No disclosure on file
Olivier Outteryck	Olivier Outteryck has nothing to disclose.
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Biljana Beretich, MD	No disclosure on file
Pavel Tishuk, MD	No disclosure on file
Daniel Becker, MD	Dr. Becker has nothing to disclose.
Christine Belden	Christine Belden has nothing to disclose.
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Rosa Capozzo	No disclosure on file
Charles Cho	No disclosure on file
Anne D. Yacoub, MD	Dr. Yacoub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
David Hojnacki, MD, F�鶹��ýӳ��	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Karen Dudich, MD	No disclosure on file
Takafumi Hosokawa	No disclosure on file
Tor-Bjorn Kall, MD	No disclosure on file
Martin Kavec, PhD	No disclosure on file
Christine Lebrun Frenay, MD, F�鶹��ýӳ��	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Mena Milad	No disclosure on file
Taizen Nakase	Taizen Nakase has nothing to disclose.
Maurizio Moggio, MD	No disclosure on file
J S. Poceta, MD	No disclosure on file
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to �鶹��ýӳ�� interests or activities.
Hans Linda, MD	No disclosure on file
Maria Esmeralda Quartuccio	No disclosure on file
Markus Schmidt, MD, PhD	No disclosure on file
Michael W. Weiner, MD	Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dolby Family Ventures. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuicals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoibnt. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Owkin France. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quantum Leap Health. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sai MedPartners. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDA Corp.. Dr. Weiner has stock in Anven. Dr. Weiner has stock in Alzeca. Dr. Weiner has stock in Alzheon, Inc.. Dr. Weiner has stock in ALZpath. The institution of Dr. Weiner has received research support from NIH/NIA; National Institutes of Health/National Institutes of Aging. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Merck Sharp & Dohme. Dr. Weiner has received personal compensation in the range of $0-$499 for serving as a Speaker/Presenter with BrightFocus Foundation. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Banner Health.
Cui Yang, MD	No disclosure on file
Megan Donohue, MD	Dr. Donohue has nothing to disclose.
Salvatore DiMauro, MD	No disclosure on file
Colette G. Donaghy, MD	Colette G. Donaghy, MC MRCP has nothing to disclose.
Michael Grundman, MD, MPH	Dr. Grundman has received personal compensation for serving as an employee of Global R&D Partners.
Connie Lau, MS, CCRC	No disclosure on file
Joyce K. Lee-Iannotti, MD, F�鶹��ýӳ��	Dr. Lee-Iannotti has nothing to disclose.
Osman Mir, MD	No disclosure on file
Angel L. Guerrero	No disclosure on file
Daniel F. Hanley, MD, F�鶹��ýӳ��	Dr. Hanley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurotrope. Dr. Hanley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. The institution of Dr. Hanley has received research support from NIH/NCATS. The institution of Dr. Hanley has received research support from NIH/NINDS.
Shuhei Nishiyama, MD	No disclosure on file
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Carla Tortorella	No disclosure on file
Vesna Vargek-Solter, MD	No disclosure on file
Helene Zephir	Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Salah G. Keyrouz, MD	No disclosure on file
Angela La Neve	No disclosure on file
Georgia D. Montouris, MD	No disclosure on file
Tatsushi Mutoh, MD	No disclosure on file
Ovallath Thazha K. Sujith, MD	Dr. Sujith has nothing to disclose.
Blanca R. Vazquez, MD	Dr. Vazquez has nothing to disclose.
Florent Borgel, MD	No disclosure on file
Maria E. Gonzalez Toledo, MD	No disclosure on file
Line E. Hviid	No disclosure on file
Timothy J. Ingall, MBBS, PhD	Dr. Ingall has nothing to disclose.
Terri J. Kiernan, NP	No disclosure on file
Kirti Patil	No disclosure on file
Amy R. Borenstein, PhD, F�鶹��ýӳ��	No disclosure on file
Bertrand Fontaine, MD	No disclosure on file
Ken Ikeda, MD, PhD	No disclosure on file
Ludwig Kappos, MD, F�鶹��ýӳ��	Dr. Kappos has nothing to disclose.
David Laplaud	No disclosure on file
Sarah Brittain, MS CCC SLP	No disclosure on file
Sydney Cash, MD	Dr. Cash has received stock or an ownership interest from Beacon Biosignals.
Luigi Ferini-Strambi, MD	Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Ferini-Strambi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for idorsia. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bruno Farmaceutici. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Sleep Medicine.
Jerome Grimaud	No disclosure on file
Kenneth P. Johnson, MD	No disclosure on file
Vivien H. Lee, MD, F�鶹��ýӳ��	Dr. Lee has nothing to disclose.
Tobias Loddenkemper, MD, F�鶹��ýӳ��	No disclosure on file
Romain Marignier, MD, PhD	Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE.
Trent P. McLaughlin, PhD	No disclosure on file
Kerry R. Mills, MD	No disclosure on file
Peter N. Riskind, MD, PhD	No disclosure on file
Max R. Trenerry, PhD	No disclosure on file
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Aaron L. Berkowitz, MD, PhD, F�鶹��ýӳ��	Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill �鶹��ýӳ��. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
Patricio S. Espinosa, MD, MPH, F�鶹��ýӳ��	Dr. Espinosa has nothing to disclose.
Xuan Feng, PhD	The institution of Dr. Feng has received research support from BMS.
Claudia S. Kay, MD	Dr. Kay has nothing to disclose.
Izumi Kawachi, MD, PhD	Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Mochida Pharmaceutical CO., LTD.. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Euroimmune. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. Kawachi has received research support from JSPS KAKENHI. Dr. Kawachi has received research support from MHLW Research Program on Rare and Intractable Diseases. Dr. Kawachi has received research support from Japan Kampo Medicine �鶹��ýӳ�� Foundation.
Carlene W. Kingston, MD	No disclosure on file
Danielle G. Koby	No disclosure on file
Christoph Pohl, MD	No disclosure on file
Sandra Vukusic, MD	The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Mary Lou Watson, BA, CCRP, RRT	No disclosure on file
Giovanni B. Zimatore, MD	No disclosure on file
Jeremy M. Shefner, MD, PhD, F�鶹��ýӳ��	Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Antonia Ceccarelli, MD, PhD	No disclosure on file
Maria D'Angelo, MD	No disclosure on file
Aaron Ellenbogen, DO	Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Diego Garcia-Borreguero, MD	No disclosure on file
Jon Infante Ceberio	No disclosure on file
Katherine Knox, MD	No disclosure on file
Seo Hyun Kim, MD, PhD	No disclosure on file
Michael R. Schoenberg, PhD, ABPP-CN	No disclosure on file
Gilles Chopard	No disclosure on file
Mustapha A. Danesi, MD	No disclosure on file
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Suvendrini Lena, MD, MPH	No disclosure on file
Pippa S. Loupe, PhD	No disclosure on file
Rupert Sandbrink, MD, PhD	Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Amy Wong	No disclosure on file
Antonio Uccelli, MD	An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Nazem Atassi, MD	Dr. Atassi has received personal compensation for serving as an employee of Sanofi. Dr. Atassi has stock in Sanofi.
Dominic B. Fee, MD, F�鶹��ýӳ��	An immediate family member of Dr. Fee has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Spine Journal. The institution of Dr. Fee has received research support from ALS Association. The institution of an immediate family member of Dr. Fee has received research support from Veterans Administration.
Deborah M. Miller, PhD	Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Michael G. Hennerici, MD	No disclosure on file
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
R. Michael Gendreau	No disclosure on file
Slavco Toncev	No disclosure on file
Mauro Zaffaroni	No disclosure on file
Douglas C. Wallace	No disclosure on file
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Gordana Toncev, MD	No disclosure on file
Reuben M. Valenzuela, MD	No disclosure on file
David F. Tang-Wai, MD, FRCPC	Dr. Tang-Wai has nothing to disclose.
Annabel K. Wang, MD, F�鶹��ýӳ��	Dr. Wang has nothing to disclose.
A C. Williams, MD	No disclosure on file
Ronald B. Ziman, MD, FACP, F�鶹��ýӳ��	No disclosure on file
Jeyaraj D. Pandian, MD, DM	Dr. Pandian has nothing to disclose.
Jesus Rivera Navarro	No disclosure on file
Claudia Robertson	The institution of Claudia Robertson has received research support from Department of Defense. The institution of Claudia Robertson has received research support from NIH. The institution of an immediate family member of Claudia Robertson has received research support from BARDA. Claudia Robertson has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH.
Walter Swardfager, MSc	No disclosure on file
Richard E. Temes, MD	No disclosure on file
Maria R. Tola, MD	No disclosure on file
P. Vijaya, MD	No disclosure on file
Nasreen Sayed	No disclosure on file
Victor H. Patterson, MD	No disclosure on file
Daniel Schneider, MD	No disclosure on file
Naganand Sripathi, MD	Dr. Sripathi has nothing to disclose.
Joanne Riphagen	No disclosure on file
David P. Salmon, PhD	Dr. Salmon has nothing to disclose.
Kurupath Radhakrishnan, MD, F�鶹��ýӳ��	No disclosure on file
Ely S. Simon, MD	No disclosure on file
Francois Tison, MD, PhD	No disclosure on file
Vahid Tohidi, MD, PhD	Dr. Tohidi has nothing to disclose.
Amanda VanDenburgh	No disclosure on file
Amy K. Sullivan, MD, PhD	No disclosure on file
Kavita M. Grover, MD, F�鶹��ýӳ��	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Ahmed Hassan, MD	No disclosure on file
Melina Jones, PhD	No disclosure on file
Alan H. Kurland, MD, F�鶹��ýӳ��	No disclosure on file
Paolo Lamberti	No disclosure on file
De-Hyung Lee, MD	No disclosure on file
Pablo Lopez, MD	No disclosure on file
Wendy C. Ziai, MD	Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ziai has received research support from NIH. Dr. Ziai has received publishing royalties from a publication relating to health care. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant with DOJ.
Rehan Verjee	No disclosure on file
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Kymberly Gyure, MD	No disclosure on file
Nam Hee Kim, MD	No disclosure on file
Sonal Mehta, MD	Dr. Mehta has nothing to disclose.
Vikram Shakkottai, MD, PhD	The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Mayowa Owolabi, MD, F�鶹��ýӳ��	Dr. Owolabi has nothing to disclose.
Eric Racine, PhD	No disclosure on file
Jay H. Rosenberg, MD, F�鶹��ýӳ��	Dr. Rosenberg has nothing to disclose.
Leon A. Weinstock, MD	Dr. Weinstock has nothing to disclose.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Amanda C. Peltier, MD, MS	Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
Philippe A. Saxe, MD	No disclosure on file
Yashpal Singh, MD	No disclosure on file
Sajith Sukumaran, MD, MBBS, DM, FRCP (London)	No disclosure on file
Robert J. Wityk, MD	No disclosure on file
Albert C. Ludolph, MD	Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ludolph has received personal compensation in the range of $0-$499 for serving as a Consultant for FundaMental Pharma . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biologix FZCo.. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
Yoshiki Takai, MD	No disclosure on file
Raya Wehbeh, MD	No disclosure on file
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Rina Takano	No disclosure on file
H. E. Hinson, MD, MCR, F�鶹��ýӳ��	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Christopher D. Lee, MD	Dr. Lee has nothing to disclose.
David J. Rintell	No disclosure on file
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Paulo J. Lorenzoni, MD	Dr. Lorenzoni has nothing to disclose.
Frederick E. Munschauer III, MD, F�鶹��ýӳ��	Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Olubunmi A. Ogunrin, MD	No disclosure on file
Amy Pace, ScD	No disclosure on file
Tetsuya Takahashi, PhD	No disclosure on file
Jose F. Tellez Zenteno, MD, PhD, FRCP	No disclosure on file
Pierre Thomas	No disclosure on file
Jerry M. Tolson, PhD	No disclosure on file
Sandrine Wiertlewski	No disclosure on file
Ana Verdelho, MD	No disclosure on file
Soe S. Mar, MD, F�鶹��ýӳ��	The institution of Dr. Mar has received research support from NIH.
Luciana Melamud	No disclosure on file
Adesola Ogunniyi, MD	Dr. Ogunniyi has nothing to disclose.
Taofiki A. Sunmonu, MD, F�鶹��ýӳ��	Dr. Sunmonu has nothing to disclose.
Maia Tchikviladze, MD	No disclosure on file
Lineu C. Werneck, MD	No disclosure on file
Stephen Thein, PhD	No disclosure on file
Christine Tranchant, MD	No disclosure on file
Sandeep Vaishnavi, MD, PhD	No disclosure on file
Domenico Inzitari, MD	No disclosure on file
Marieke Visser	No disclosure on file
Ignacio Mateo Fernandez	No disclosure on file
Aurelie Ruet	The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Gunhild Waldemar, MD, DMSc	No disclosure on file
John Winkelman, MD, PhD	John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. John Winkelman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Azurity. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Disc Medicine. An immediate family member of John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noctrix. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Psychogenics. The institution of John Winkelman has received research support from American Regent. The institution of John Winkelman has received research support from Merck. John Winkelman has received publishing royalties from a publication relating to health care. John Winkelman has a non-compensated relationship as a Chair with International Restless Legs Syndrome Study Group that is relevant to �鶹��ýӳ�� interests or activities. John Winkelman has a non-compensated relationship as a Member with Restless Legs Syndrome Foundation Scientific Medical Advisory Board that is relevant to �鶹��ýӳ�� interests or activities.
Brigitte Stemper, MD	No disclosure on file
Akihiro Sugai, MD	The institution of Dr. Sugai has received research support from Japan Society for the Promotion of Science. The institution of Dr. Sugai has received research support from SERIKA FUND. The institution of Dr. Sugai has received research support from Japan Agency for Medical Research and Development.
Philip Scheltens, MD, PhD, F�鶹��ýӳ��	Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Doreen Ho, MD	Dr. Ho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
Armando S. Miciano, MD, FAAPMR	No disclosure on file
Daniel Ontaneda, MD, PhD, F�鶹��ýӳ��	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Gerald Pfeffer, MD, PhD	Dr. Pfeffer has received research support from Canadian Institutes of Health Research.
Michael J. Reding, MD	No disclosure on file
William J. McIlroy, MD	No disclosure on file
Ingrid Park, MD	No disclosure on file
Luisa M. Villar	Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Metha Apiwattanakul, MD	Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for teva. Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Orhan Aktas, MD	Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Yong Won Cho, MD	No disclosure on file
Sarah E. DeRossett, MD, PhD	No disclosure on file
As'ad Ehtisham, MD	No disclosure on file
Ana Isabel Fumagalli, MD	No disclosure on file
Michael Hennessy	No disclosure on file
Jonathan S. Katz, MD	Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Denise L. Milovan, PhD	No disclosure on file
Timothy L. Williams	No disclosure on file
Mark R. Baker, MBBS, PhD, MRCP	No disclosure on file
Paolo Livrea	No disclosure on file
John W. McDonald III, MD, PhD	No disclosure on file
Jean-Christophe Bier, Sr., MD	Dr. Bier has nothing to disclose.
Kevin B. Boylan, MD	No disclosure on file
Jodie Burton, MD, F�鶹��ýӳ��	Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to �鶹��ýӳ�� interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to �鶹��ýӳ�� interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to �鶹��ýӳ�� interests or activities. Dr. Burton has a non-compensated relationship as a �鶹��ýӳ��al Chair with EMD Serono that is relevant to �鶹��ýӳ�� interests or activities.
Eustachio D'Errico	No disclosure on file
Efthymia Gavala	No disclosure on file
Ihab Hajjar	Ihab Hajjar has nothing to disclose.
Hen Hallevi, MD	No disclosure on file
Maria Kataki, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Hans D. Katzberg, MD, F�鶹��ýӳ��	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Suzee Lee, MD	Dr. Lee has nothing to disclose.
Carlos A. Vrech, MD	No disclosure on file
Scott Vota, DO, F�鶹��ýӳ��	No disclosure on file
Roy E. Strowd III, MD, F�鶹��ýӳ��	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Anthony Chen, MD	No disclosure on file
Neelofer Shafi, MD	Dr. Shafi has nothing to disclose.
Giacomo Lus	Giacomo Lus has nothing to disclose.
Beatriz Tijero Merino, MD	No disclosure on file
Stanley Fisher, MD, F�鶹��ýӳ��	Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Dolora R. Wisco, MD	Dr. Wisco has nothing to disclose.
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to �鶹��ýӳ�� interests or activities.
Mehmet Yucel, MD	No disclosure on file
Dinesh G. Nair, MD	No disclosure on file
Grisel J. Lopez, MD	Dr. Lopez has nothing to disclose.
Melissa C. Lipford, MD	Dr. Lipford has nothing to disclose.
Alexandra M. Soriano Caminero, MD	No disclosure on file
Sanjeeva R. Onteddu, MD, F�鶹��ýӳ��	Dr. Onteddu has nothing to disclose.
Joshua J. Weaver, MD, F�鶹��ýӳ��	Dr. Weaver has nothing to disclose.
Alison May, MD	No disclosure on file
Jason D. Hinman, MD, PhD	Dr. Hinman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bertoldo, Baker, Carter & Smith. Dr. Hinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Koskoff, Koskoff & Bieder. Dr. Hinman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Matthew Millea, PC. Dr. Hinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Popham Law Firm PC. Dr. Hinman has received stock or an ownership interest from Sage Cerebrovascular Diagnostics, Inc.. Dr. Hinman has received research support from NIH. Dr. Hinman has received research support from American Heart Association. Dr. Hinman has received research support from Reneuron. Dr. Hinman has received intellectual property interests from a discovery or technology relating to health care.
Lara K. Ronan, MD, F�鶹��ýӳ��	No disclosure on file
Robert T. Knipe, DO	No disclosure on file
John K. Lynch, DO, MPH	Dr. Lynch has nothing to disclose.
David M. Ermak, DO	Dr. Ermak has nothing to disclose.
Gail F. Tarlton, NP	No disclosure on file
Andrei Ivashynka, MD, PhD	Dr. Ivashynka has nothing to disclose.
Clotilde Hainline, MD	Dr. Hainline has nothing to disclose.
Luiz Felipe R. Vasconcellos, MD	No disclosure on file
Donna Tippett	No disclosure on file
Xiangping Zhou, MD, PhD	No disclosure on file
Francis M. Gengo, PharmD	No disclosure on file
Shaun Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences.
Deepa Bhupali, MD	Dr. Bhupali has nothing to disclose.
Marcela Parada Marcilla, MD	No disclosure on file
Jenny Kim	No disclosure on file
Yujuan Jiao	No disclosure on file
Amanda M. Moen, MD	No disclosure on file
Steven Tobochnik, MD	An immediate family member of Dr. Tobochnik has received personal compensation for serving as an employee of Google. Dr. Tobochnik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blackrock Neurotech. Dr. Tobochnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blackrock Neurotech. The institution of Dr. Tobochnik has received research support from US Department of Veterans Affairs.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Walter O. Arruda, MD, PhD	Dr. Arruda has nothing to disclose.
Vernice E. Bates, MD	No disclosure on file
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Angel Vinuela Cabezas De Herrera, MD	No disclosure on file
Omar Baez, MD	No disclosure on file
Maria J. Bruzzone, MD, F�鶹��ýӳ��	Dr. Bruzzone has nothing to disclose.
Koto Ishida, MD, F�鶹��ýӳ��	Dr. Ishida has received publishing royalties from a publication relating to health care.
Ben Lenail	No disclosure on file
Zachary Grinspan, MD	Dr. Grinspan has received personal compensation for serving as an employee of Weill Cornell Medicine. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Insights. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharma LTD (South Korea). Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. The institution of Dr. Grinspan has received research support from SLC6A1 Connect. The institution of Dr. Grinspan has received research support from STXBP1 Foundation. The institution of Dr. Grinspan has received research support from Clara Inspired. The institution of Dr. Grinspan has received research support from Amgen. The institution of Dr. Grinspan has received research support from NINDS. Dr. Grinspan has received intellectual property interests from a discovery or technology relating to health care.
Daniel Vela-Duarte, MD	Dr. Vela-Duarte has nothing to disclose.
Rainer W. Paine, MD, PhD	No disclosure on file
Catherine Hosley, MD	No disclosure on file
Alexandra S. Reynolds, MD	Dr. Reynolds has nothing to disclose.
Phillip L. Pearl, MD, F�鶹��ýӳ��	Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Joseph J. Sabatino, Jr., MD	The institution of Dr. Sabatino has received research support from Roche/Genentech.
Megan M. Barry, MD	Dr. Barry has nothing to disclose.
Laura F. Parolin, MD	No disclosure on file
Enrique A. Serrano, MD	No disclosure on file
Jamal N. Muthana, MD	No disclosure on file
Holly Wilhalme	No disclosure on file
Jacob L. Kaufman, MD	No disclosure on file
Ghulam Mustafa, MD, MBBS	No disclosure on file
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Barbara A. Dworetzky, MD, F�鶹��ýӳ��	Dr. Dworetzky has received publishing royalties from a publication relating to health care.
Alan C. Carver, MD	No disclosure on file
Benjamin M. Laitman	No disclosure on file
Doulia Hamad	No disclosure on file
Vasu Saini, MD	Dr. Saini has nothing to disclose.
Maria del Carmen Garcia	No disclosure on file
Susan Shaw, MD	No disclosure on file
Christian J. Camargo, MD	Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Health. The institution of Dr. Camargo has received research support from �鶹��ýӳ��.
Ann Camac, MD	No disclosure on file
Sunhee C. Lee, MD	No disclosure on file
Bryan D. Walker, PA	Mr. Walker has received personal compensation for serving as an employee of EMD Serono.
Sachin Kedar, MD, F�鶹��ýӳ��	Dr. Kedar has nothing to disclose.
Fred W. Turek, PhD	No disclosure on file
Felix Schmidt	No disclosure on file
Thomas A. Buckley, PhD	The institution of Dr. Buckley has received research support from Highmark Bluecross Blue Prints. The institution of Dr. Buckley has received research support from NIH/NINDS. The institution of Dr. Buckley has received research support from StateSpace, Inc.
Toby I. Gropen, MD	Dr. Gropen has nothing to disclose.
Karthik Rao	No disclosure on file
Eric Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
Ryan Hays, MD, MBA, FAES, F�鶹��ýӳ��	Dr. Hays has nothing to disclose.
Ahmed A. Malik, MD	No disclosure on file
Jamal F. Khattak, MD	Dr. Khattak has nothing to disclose.
L. C. Turtzo, MD, PhD	No disclosure on file
Tarun Singhal, MD	Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana LifeSciences. The institution of Dr. Singhal has received research support from Novartis. The institution of Dr. Singhal has received research support from Department of Defense. The institution of Dr. Singhal has received research support from Foundation for Neurologic Diseases.
Richard T. Benson, MD, PhD, F�鶹��ýӳ��	Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journals (�鶹��ýӳ��). Dr. Benson has received personal compensation in the range of $100,000-$499,999 for serving as a Federal employee with HHS/NIH.
Karanbir Singh, MD	No disclosure on file
Eyal Muscal	Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Nazanin Matloubi, MD	No disclosure on file
Ashley E. Thomas, MD	No disclosure on file
Jeremy Tanner, MD	An immediate family member of Dr. Tanner has received personal compensation for serving as an employee of Channeling Hope Foundation. The institution of Dr. Tanner has received research support from NIA, NINDS. Dr. Tanner has a non-compensated relationship as a Chief Scientific Officer with Channeling Hope Foundation that is relevant to �鶹��ýӳ�� interests or activities.
Seth A. Smith, PhD	Dr. Smith has nothing to disclose.
Angelos Katramados, MD	Dr. Katramados has nothing to disclose.
Monica B. Perassolo, MD	No disclosure on file
Alla Borisovna Guekht, PhD	The institution of Prof. Guekht has received research support from Russian Science Foundation .
Deepti Zutshi, MD, F�鶹��ýӳ��	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Rebecca E. Wells, MD, F�鶹��ýӳ��	The institution of Dr. Wells has received research support from NIH. Dr. Wells has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Southern Headache Society. Dr. Wells has a non-compensated relationship as a Board member with Southern Headache Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Wells has a non-compensated relationship as a Board member with American Headache Society that is relevant to �鶹��ýӳ�� interests or activities.
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Nasheed I. Jamal, MD, F�鶹��ýӳ��	Dr. Jamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Jamal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Jamal has received research support from NIH-NIAMS.
Harina K. Chahal, MD	No disclosure on file
Jennifer Whitwell, PhD	The institution of Dr. Whitwell has received research support from NIH.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Muhammed Said Berilgen	No disclosure on file
Seref Demirkaya, PhD	No disclosure on file
Henrikas Vaitkevicius, MD	Dr. Vaitkevicius has received personal compensation for serving as an employee of Noema Pharmaceuticals. Dr. Vaitkevicius has stock in Noema Pharmaceuticals.
Rahul Remanan, MBBS	No disclosure on file
Jaskiran Brar, MD	No disclosure on file
Khalid S. Alqadi, MD	No disclosure on file
Gorm Pihl-Jensen	No disclosure on file
Michael J. Lyerly, MD, F�鶹��ýӳ��	Dr. Lyerly has nothing to disclose.
Augusto A. Miravalle, MD, F�鶹��ýӳ��	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Jennifer P. Rubin, MD	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Passage Bio.
Anand V. Patel, MD	Dr. Patel has nothing to disclose.
Luis Guada-Delgado, MD	Dr. Guada-Delgado has nothing to disclose.
Abhishek Lunagariya, MD	No disclosure on file
Ilia Itin, MD	No disclosure on file
Heather Gordish-Dressman	Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AGADA Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Statistical reviewer with TREAT-NMD TACT Committee.
Ashish Kulhari, MD	No disclosure on file
Janace Hart	No disclosure on file
Raphael Spera, Sr., MD	No disclosure on file
Daniel Landau, MD	No disclosure on file
Immaculada Aban	No disclosure on file
Gloria Kim	No disclosure on file
Abdulrahman Bouges, MBBS	No disclosure on file
Michelle U. Van Noord, MD	No disclosure on file
Lauren M. Massimo, PhD	No disclosure on file
Catherine Maurice, MD	No disclosure on file
Sharan Paul, PhD	Dr. Paul has nothing to disclose.
Michal Szulc	No disclosure on file
Catherine Tegeler	Ms. Tegeler has nothing to disclose.
David Collas, MD	No disclosure on file
Eyal Y. Kimchi, MD, PhD	The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.
Ulrike Kaunzner, MD	Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Hunter Collins, MD	No disclosure on file
Bradley Molyneaux, MD, PhD	Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Billing, Cochran, Lyles, Mauro and Ramsey. The institution of Dr. Molyneaux has received research support from NIH. Dr. Molyneaux has received publishing royalties from a publication relating to health care.
Roya Vakili, MD	Dr. Vakili has nothing to disclose.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Reuben Burshtein, MD	No disclosure on file
Francisco Germiniani	No disclosure on file
Hossam A. Shaltout, PhD	Dr. Shaltout has nothing to disclose.
Avinash R. Sagi, MBBS	No disclosure on file
Maria Antonietta Mazzola, MD	Dr. Mazzola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec.
Raquel Custodio Da Silveira, MD	No disclosure on file
Samuel T. Carrell, MD, PhD	The institution of Dr. Carrell has received research support from �鶹��ýӳ��.
Joshua N. Daniel, MD	No disclosure on file
Alessandro D'Ambrosio	No disclosure on file
Oladunni Ogundare, MD	No disclosure on file
Jigar P. Mankad, MD	Dr. Mankad has nothing to disclose.
Shawna M. Cutting, MD, F�鶹��ýӳ��	The institution of Dr. Cutting has received research support from Genentech.
Eric B. Schneider, PhD	No disclosure on file
Larissa Vilany	No disclosure on file
Lidia Sarro, MD	No disclosure on file
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Stephanie Grover, MSc, CCRP	No disclosure on file
Alberto Cucca, MD	No disclosure on file
Mena Samaan, MD	No disclosure on file
Kailie Luan, MD	No disclosure on file
Yamin Shwe, MD	No disclosure on file
christian N. shenouda	No disclosure on file
Dara Dickstein, PhD	No disclosure on file
Tim-Henrik Bruun, PhD	No disclosure on file
Daniel Korya, MD	No disclosure on file
Julia A. Collison	No disclosure on file
Boskovski Bojan	No disclosure on file
Daniella Miller, MD	Dr. Miller has nothing to disclose.
Brian T. Perrin, MD	No disclosure on file
Elizabeth H. Wise, APRN	Ms. Wise has nothing to disclose.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Paul Spanel, DO	No disclosure on file
Robert I. Reid	No disclosure on file
Franck G. Amyot, PhD	Dr. Amyot has nothing to disclose.
Francisco E. Gomez III, MD	No disclosure on file
David M. Dawson, MD, F�鶹��ýӳ��	No disclosure on file
Jon Elofson	No disclosure on file
Muruvvet Nur Eroglu	No disclosure on file
Sung Yim, MD	No disclosure on file
Jason D. Morgenstern	No disclosure on file
Chava A. Creque	No disclosure on file

�鶹��ýӳ��

�鶹��ýӳ��